Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
Condition(s):Parenteral Nutrition Associated Liver DiseaseLast Updated:January 5, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Parenteral Nutrition Associated Liver DiseaseLast Updated:January 5, 2021Completed
Condition(s):Cholestasis; Parenteral Nutrition Associated Liver Disease (PNALD)Last Updated:September 7, 2011Unknown status
Condition(s):Parenteral NutritionLast Updated:March 25, 2020Withdrawn
Condition(s):Esophageal AtresiaLast Updated:September 16, 2019Withdrawn
Condition(s):Essential Fatty Acid Deficiency (EFAD)Last Updated:December 27, 2023Completed
Condition(s):Very Long-chain Acyl-CoA Dehydrogenase Deficiency; Trifunctional Protein Deficiency; Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency; Medium-chain Acyl-CoA Dehydrogenase Deficiency; Normal Volunteers; Carnitine Palmitoyltransferase II Deficiency, MyopathicLast Updated:January 30, 2024Completed
Condition(s):Parenteral NutritionLast Updated:October 17, 2018Completed
Condition(s):Myocardial InjuryLast Updated:May 11, 2022Not yet recruiting
Condition(s):Total Parenteral Nutrition-induced CholestasisLast Updated:February 6, 2020Withdrawn
Condition(s):HIV InfectionsLast Updated:February 20, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.